In this article, the scientific evidence and professional guidelines regarding the timing of antiretroviral therapy initiation are reviewed, with discussion of the increasingly persuasive evidence in favor of starting treatment early in the course of human immunodeficiency virus disease
Background: According to consensus, initiation of therapy is best based on CD4 cell count, a mark...
Use of antiretroviral treatment for HIV-1 infection has decreased AIDS-related morbidity and mortali...
Abstract: Background: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, Wor...
In this article, the scientific evidence and professional guidelines regarding the timing of antiret...
Background Strategies for use of antiretroviral therapy (ART) have traditionally focused on providin...
BACKGROUND: For people with HIV and CD4+ counts >500 cells/mm3, early initiation of antiretroviral t...
BACKGROUND: For people with HIV and CD4+ counts >500 cells/mm3, early initiation of antiretroviral t...
BACKGROUND: For people with HIV and CD4+ counts >500 cells/mm3, early initiation of antiretroviral t...
To the Editor: In their Perspective article, De Cock and El-Sadr (March 7 issue)1 highlight the nee...
Copyright © 2014 Babatunde Olubajo et al. This is an open access article distributed under the Creat...
Copyright © 2014 Matthias Haering et al. This is an open access article distributed under the Creati...
International audienceBACKGROUND: The CD4 cell count at which combination antiretroviral therapy sho...
International audienceBACKGROUND: The CD4 cell count at which combination antiretroviral therapy sho...
Background: Many analyses of HIV treatment decisions assume a fixed formulary of HIV drugs. However,...
International audienceBACKGROUND: The CD4 cell count at which combination antiretroviral therapy sho...
Background: According to consensus, initiation of therapy is best based on CD4 cell count, a mark...
Use of antiretroviral treatment for HIV-1 infection has decreased AIDS-related morbidity and mortali...
Abstract: Background: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, Wor...
In this article, the scientific evidence and professional guidelines regarding the timing of antiret...
Background Strategies for use of antiretroviral therapy (ART) have traditionally focused on providin...
BACKGROUND: For people with HIV and CD4+ counts >500 cells/mm3, early initiation of antiretroviral t...
BACKGROUND: For people with HIV and CD4+ counts >500 cells/mm3, early initiation of antiretroviral t...
BACKGROUND: For people with HIV and CD4+ counts >500 cells/mm3, early initiation of antiretroviral t...
To the Editor: In their Perspective article, De Cock and El-Sadr (March 7 issue)1 highlight the nee...
Copyright © 2014 Babatunde Olubajo et al. This is an open access article distributed under the Creat...
Copyright © 2014 Matthias Haering et al. This is an open access article distributed under the Creati...
International audienceBACKGROUND: The CD4 cell count at which combination antiretroviral therapy sho...
International audienceBACKGROUND: The CD4 cell count at which combination antiretroviral therapy sho...
Background: Many analyses of HIV treatment decisions assume a fixed formulary of HIV drugs. However,...
International audienceBACKGROUND: The CD4 cell count at which combination antiretroviral therapy sho...
Background: According to consensus, initiation of therapy is best based on CD4 cell count, a mark...
Use of antiretroviral treatment for HIV-1 infection has decreased AIDS-related morbidity and mortali...
Abstract: Background: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, Wor...
DOI
Add to ORKG